Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris

Prediction of potential public health risk of the recent multicountry monkeypox outbreak: An update after the end declaration of global public health emergency

“…Besides, healthcare professionals must be extra cautious during the diagnosis of mpox, especially when handling needles or swabs and during the time of providing treatment. 44 In addition, the deceased body should be transferred to the morgue as early as possible by properly wrapping it with cloth or shroud to prevent fluid leakage or keeping lesions open to the environment. 45 To prevent the spread of mpox from hospitals other than patient isolation or gown, gloves, PPE use, instructions on room cleaning, or specimen handling were adopted in many hospitals.…”

Global Health Alert: Racing to Control Antimicrobial Resistant Candida auris and Waste Using UVC LED Technology

“…Additional steps using alcohol-based sanitizers are needed to reach maximal disinfection from the skin [104]. When using alcohol-based sanitizers, at least one minute of wet contact time is necessary to achieve disinfection; however, the standard hand sanitation time for healthcare professionals is often under 15 seconds [163]. Even using optimal conditions, chlorohexidine (0.5%-4.0%) and other common alcohol disinfectants often achieve less than a 3-log10 reduction.…”

Inactivation and/or physical removal of Candida auris from floors by detergent cleaner, disinfectants, microfiber, and ultraviolet C light (UV-C)

“…Candida auris is an emerging multidrug-resistant fungus that can cause invasive disease in critically ill patients with a mortality rate as high as 30%-60%. 1 Increasing numbers of infections have been identified since it was first identified in Japan in 2009. In the United States, C. auris was made nationally notifiable in 2018.…”

“…1 C. auris presents a serious global health threat for several reasons to include the following: causes serious infections with high mortality; antifungal treatment options are limited; increasing prevalence; biofilm formation; has caused multiple outbreaks in healthcare facilities; persists on environment surfaces for days to weeks; a person can be colonized (or infected) with C. auris and shed it into the environment; C. auris can be spread from person-to-person directly via touch or secondarily through contact with contaminated surfaces and medical equipment; and C. auris is not rapidly inactivated by some commonly used disinfectants (eg, quaternary ammonium compounds diluted in water). [1][2][3] Patients with comorbidities, patients with immunosuppressive conditions, and patients on ventilators are more likely to develop C. auris infection. 1 Floors are contaminated with Candida spp, 4 and there is indirect evidence supporting the potential for transfer of pathogens from floors to patients.…”

“…[1][2][3] Patients with comorbidities, patients with immunosuppressive conditions, and patients on ventilators are more likely to develop C. auris infection. 1 Floors are contaminated with Candida spp, 4 and there is indirect evidence supporting the potential for transfer of pathogens from floors to patients. 5 Deshpande et al 6 showed that surfaces such as blood-pressure cuffs and call buttons were often in contact with the floor and in contact with those objects frequently resulted in transfer of pathogens to hands.…”